Anrukinzumab (IMA-638) is a humanized monoclonal antibody that targets interleukin-13 (IL-13), a cytokine implicated in the pathogenesis of several inflammatory conditions. This antibody has demonstrated efficacy in reducing lung inflammation in cynomolgus monkey models, highlighting its potential utility in pulmonary research. Anrukinzumab is suitable for use in investigations into the mechanisms and treatment of diseases such as ulcerative colitis and asthma, providing a valuable tool for both basic research and therapeutic development.
Anrukinzumab (IMA-638) is a humanized monoclonal antibody that targets interleukin-13 (IL-13), a cytokine implicated in the pathogenesis of several inflammatory conditions. This antibody has demonstrated efficacy in reducing lung inflammation in cynomolgus monkey models, highlighting its potential utility in pulmonary research. Anrukinzumab is suitable for use in investigations into the mechanisms and treatment of diseases such as ulcerative colitis and asthma, providing a valuable tool for both basic research and therapeutic development.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
